Perspective Therapeutics (CATX) EBT (2010 - 2026)

Perspective Therapeutics has disclosed EBT across 17 years of filings, most recently posting -$27.0 million for Q2 2026.

• In Q2 2026, EBT fell 22.66% year-over-year to -$27.0 million; the TTM figure through Jun 2026 stood at -$120.0 million (down 21.77% YoY), while the FY2025 annual figure was -$104.4 million, down 28.33% from the prior year.
• EBT came in at -$27.0 million for Q2 2026 at Perspective Therapeutics, up from -$28.7 million in the prior quarter.
• In the past five years, EBT ranged from a high of -$1.3 million in Q1 2022 to a low of -$43.2 million in Q4 2024.
• Average EBT over 5 years is -$17.2 million, with a median of -$13.5 million recorded in 2024.
• Year-over-year, EBT slumped 707.05% in 2023 and gained 11.41% in 2025.
• Over 5 years, EBT stood at -$7.3 million in 2022, then plunged by 129.39% to -$16.8 million in 2023, then sank by 156.83% to -$43.2 million in 2024, then grew by 11.41% to -$38.3 million in 2025, then gained by 29.52% to -$27.0 million in 2026.
• Per Business Quant data, the three most recent EBT figures were -$27.0 million in Q2 2026, -$28.7 million in Q1 2026, and -$38.3 million in Q4 2025.